The World Health Organization (OBSH) is naming the new variants of the coronary according to the Greek alphabet.

The ongoing spread of the SARS-CoV-2 choreography has created new variants that have prompted experts to monitor them carefully and do intensive research.

Some virus mutations that cause COVID-19 have made it more infectious and immune to vaccines.

The attention of scientists is focused on the Delta version, which is dominateing cases of the infected worldwide.

However, scientists are tracking other options to understand more than which one can take Delta's place, Reuters broadcasts.

Delta still dominating

The most disturbing of all variables remains Delta. He was first discovered in India. This option is hitting unexplored populations in many countries. He has the ability to infect a higher percentage of people than his preceding variants.

The World Health Organization (OBSH) has classified Delta as a disturbing version. So according to the definition of O BSH, it has the ability to spread faster, then to patients to cause more serious diseases, or to reduce the efficiency of vaccines and medicine for treatment.

What do we know about Option Mu?

The Superpower of Option Delta lies in the ability to spread quickly, says Shane Crotty, a virologist at the Institute of Immmology “La Jolla”, San Diego.

Chinese researchers concluded that people infected with the Delta version carry 1,260 times as many viruses in their nose as the original version of the coronary.

Some American research says that the amount of virus in vaccinated individuals infected with Delta is at the same level as those who are unexplored, but more research is needed.

Delta is also identified in the time of the presentation of symptoms from the first version of the coronary.

It took up to seven days to cause symptoms, while Delta can cause symptoms two to three days earlier, giving less time to the human immune system to respond and create a form of protection.

Lambda variations

The Lambda variation was first identified in Peru in December.

He had attracted expert attention as a new threat, but it seems he is withdrawing.

The Lambda variant cases were growing in July, but over the past four weeks, there has been a decline in the infected, according to GIAID data, a database that tracks SARS-CoV-2 variants.

O The BSH has classified Lambdan as a <x0vant interest”. When WHO puts any variant in this category, it means that it carries alleged mutations that cause a change in transparency, or cause more serious diseases, but still under research.

lab studies have shown that mutations are resistant to antibodies produced by vaccines.

Just under surveillance.

The Mu variation, or since it was previously called B.1.621, has been identified in Colombia during January.

On August 30th, WHO declared it a version of interest, due to some disturbing mutations and assigned him a name with the Greek letter MU.

The vaccine carries key mutations, including E484K, N501Y and D614G. These have to do with increasing transparency and lowering immunity protection.

Last week, in WHO's regular bulletin, the variant was said to have caused several major outbreaks of infected people in South America and Europe.

While the number of cases identified as Mu has dropped below 0.1% on a global level, this version represents 39% of cases in Colombia and 13% in Ecuador, countries where its distribution “has steadily increased”.

The Global Health Agency said it is continuing to monitor Mu version in South America, especially in areas where it circulates with the Delta version.

The head of WHO's disease unit, Maria van Kerkhove, said the circulation of this version is declining to a global level, but however it must be monitored closely.

At a media conference last week, White House leading medical adviser Anthony Fauci said American officials are monitoring this version, but so far, according to him, the Mu is not estimated to pose an immediate threat.

Vaccination and New Alternatives

Experts say that the more people have to be vaccinated, as large groups of disadvantaged people allow the virus to spread and transform into new variants.

In their view, the efforts to vaccinate must be increased internationally to avoid showing uncontrolled variants among the population in poor countries.

The vaccines currently used prevent the infected from getting seriously sick and dying, but they do not block the infection.

The virus is still able to multiply in the nose, even among the vaccinated people who can then transmit it.

Perhaps to beat the SARS-CoV-2, it should be researched for a new generation of vaccines, which will have the ability to stop the transmission of the virus, says Gregory Poland, a vaccine researcher at the Mayo Clinic.

Until then, according to him and other experts, the world will face the appearance of new coronary variants.